Literature DB >> 2263572

Geographic variation in breast cancer mortality in the United States: a hypothesis involving exposure to solar radiation.

F C Garland1, C F Garland, E D Gorham, J F Young.   

Abstract

Epidemiologic and laboratory evidence suggests that vitamin D may play a role in reducing breast cancer risk. Lack of exposure to ultraviolet sunlight can increase the prevalence of vitamin D deficiency. This deficiency may place some populations at higher risk for breast cancer. The association between total average annual sunlight energy striking the ground and age-adjusted breast cancer mortality rates in 87 regions of the United States was evaluated. Annual age-adjusted mortality rates for breast cancer varied over a 1.8-fold range, from 17-19 per 100,000 in the South and Southwest United States to 33 per 100,000 in the Northeast; the overall U.S. rate was 27.3 per 100,000. Risk of fatal breast cancer in the major urban areas of the United States was inversely proportional to intensity of local sunlight (r = -0.80, P = 0.0001); multiple regression with stratospheric ozone measurements, r = -0.82, P = 0.0001). Vitamin D from sunlight exposure may be associated with low risk for fatal breast cancer, and differences in ultraviolet light reaching the United States population may account for the striking regional differences in breast cancer mortality. The ecological nature of this study is emphasized, and the possibility that an indirect association with dietary and socioeconomic factors could explain these findings is discussed.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2263572     DOI: 10.1016/0091-7435(90)90058-r

Source DB:  PubMed          Journal:  Prev Med        ISSN: 0091-7435            Impact factor:   4.018


  104 in total

1.  Sunlight and health. Use of sunscreens does not risk vitamin D deficiency.

Authors:  R Marks
Journal:  BMJ       Date:  1999-10-16

2.  The vitamin D receptor: a tumor suppressor in skin.

Authors:  Daniel David Bikle
Journal:  Discov Med       Date:  2011-01       Impact factor: 2.970

3.  EB1089, a vitamin D receptor agonist, reduces proliferation and decreases tumor growth rate in a mouse model of hormone-induced mammary cancer.

Authors:  Erin L Milliken; Xiaoxue Zhang; Chris Flask; Jeffrey L Duerk; Paul N MacDonald; Ruth A Keri
Journal:  Cancer Lett       Date:  2005-08-22       Impact factor: 8.679

4.  Effects of 1,25 Dihydroxyvitamin D3 on Human Retinal Pigment Epithelial Cell Lines.

Authors:  Cansu Ekinci; Eray Metin Guler; Abdurrahim Kocyigit; Furkan Kirik; Hakan Ozdemir
Journal:  Int Ophthalmol       Date:  2021-05-22       Impact factor: 2.031

5.  Prospective study of ultraviolet radiation exposure and mortality risk in the United States.

Authors:  Shih-Wen Lin; David C Wheeler; Yikyung Park; Michael Spriggs; Albert R Hollenbeck; D Michal Freedman; Christian C Abnet
Journal:  Am J Epidemiol       Date:  2013-07-17       Impact factor: 4.897

Review 6.  Circulating melatonin and the risk of breast and endometrial cancer in women.

Authors:  Akila N Viswanathan; Eva S Schernhammer
Journal:  Cancer Lett       Date:  2008-12-12       Impact factor: 8.679

7.  Cholecalciferol supplementation alters calcitriol-responsive monocyte proteins and decreases inflammatory cytokines in ESRD.

Authors:  Jason R Stubbs; Arun Idiculla; Joyce Slusser; Rochelle Menard; L Darryl Quarles
Journal:  J Am Soc Nephrol       Date:  2009-12-10       Impact factor: 10.121

8.  The potential for oxytocin (OT) to prevent breast cancer: a hypothesis.

Authors:  T G Murrell
Journal:  Breast Cancer Res Treat       Date:  1995-08       Impact factor: 4.872

Review 9.  Nonclassic actions of vitamin D.

Authors:  Daniel Bikle
Journal:  J Clin Endocrinol Metab       Date:  2008-10-14       Impact factor: 5.958

10.  25-Hydroxyvitamin D3 is a natural chemopreventive agent against carcinogen induced precancerous lesions in mouse mammary gland organ culture.

Authors:  Xinjian Peng; Michael Hawthorne; Avani Vaishnav; René St-Arnaud; Rajendra G Mehta
Journal:  Breast Cancer Res Treat       Date:  2008-01-20       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.